PEG-MGF
guinea pig
The Dose Guy’s verdictAug 28, 20261 source
The idea behind PEG-MGF is good. The evidence is not. Zero human trials, no human pharmacokinetics, and a mechanism story borrowed from unpegylated MGF that was never validated past cells and rats. People run it for localized muscle repair, and the reasoning is interesting enough that I won’t call it nonsense, but I also won’t pretend there’s a receipt behind it. If local repair is the goal and you want something with actual human evidence behind it, BPC-157 and TB-500 are where I’d start.
What it is
MGF, mechano growth factor, is a splice variant of IGF-1 that your muscles produce naturally after mechanical damage, the kind training creates. The idea is that injecting it locally drives satellite cell activation and repair in the muscle you just trained. The pegylation extends its survival: unpegylated MGF breaks down in minutes in circulation, so the PEG chain buys it enough time to reach the tissue.
Everything else on the GH axis, from secretagogues like ipamorelin to HGH itself, works systemically. PEG-MGF is the local play: a repair signal your muscles already make, delivered directly to where the damage happened. The distance from human evidence grows with every step down the chain.
What the research shows
There is almost nothing here. The absence is the story:
Realistic protocols
I’m not building a protocol out of a classification in one review paper. What the community runs: 200 to 400 mcg injected intramuscularly into the trained muscle, post-workout, two to three times per week on training days only. The pegylation is supposed to give it a longer local window than unpegylated MGF. Some stack it with IGF-1 DES pre-workout, timing them apart so the growth signals arrive in sequence rather than competing. Neither compound has human data alone, so stacking them doubles an unmeasured risk.
If you run it anyway: source matters even more than usual when the compound has zero human data. Get a third-party COA and confirm what is actually in the vial. Go low, go short, and do not mistake the lack of reported sides for safety. Nobody is reporting because nobody is studying it.
Side effects
No human safety data. Everything here is community-reported or class-predicted:
